US2008227818A1PendingUtilityA1

Use of saredutant or its pharmaceutically acceptable salts in the treatment of mixed anxiety-depression disorders

59
Assignee: SANOFI AVENTISPriority: Apr 27, 1999Filed: May 21, 2008Published: Sep 18, 2008
Est. expiryApr 27, 2019(expired)· nominal 20-yr term from priority
Inventors:Xavier Emonds-AltPhilippe SoubrieRégis Steinberg
A61P 25/24A61P 25/00A61P 25/18A61K 31/451A61P 25/22
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of mixed anxiety-depression disorders.

Claims

exact text as granted — not AI-modified
1 . A method for the treatment of mixed anxiety-depression disorders which comprises administering to a patient in need of said treatment an effective amount of saredutant or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2008227818A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.